218 related articles for article (PubMed ID: 30527455)
1. Radiomics Signature: A Biomarker for the Preoperative Distant Metastatic Prediction of Stage I Nonsmall Cell Lung Cancer.
Fan L; Fang M; Tu W; Zhang D; Wang Y; Zhou X; Xia Y; Li Z; Liu S
Acad Radiol; 2019 Sep; 26(9):1253-1261. PubMed ID: 30527455
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
3. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
4. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
[TBL] [Abstract][Full Text] [Related]
5. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
7. CT Radiomics Signature of Tumor and Peritumoral Lung Parenchyma to Predict Nonsmall Cell Lung Cancer Postsurgical Recurrence Risk.
Akinci D'Antonoli T; Farchione A; Lenkowicz J; Chiappetta M; Cicchetti G; Martino A; Ottavianelli A; Manfredi R; Margaritora S; Bonomo L; Valentini V; Larici AR
Acad Radiol; 2020 Apr; 27(4):497-507. PubMed ID: 31285150
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer.
Wang T; Deng J; She Y; Zhang L; Wang B; Ren Y; Wu J; Xie D; Sun X; Chen C
Ann Thorac Surg; 2020 Jun; 109(6):1741-1749. PubMed ID: 32087134
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
Yu W; Tang C; Hobbs BP; Li X; Koay EJ; Wistuba II; Sepesi B; Behrens C; Rodriguez Canales J; Parra Cuentas ER; Erasmus JJ; Court LE; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1090-1097. PubMed ID: 29246722
[TBL] [Abstract][Full Text] [Related]
10. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
11. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
12. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
13. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
[TBL] [Abstract][Full Text] [Related]
14. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
[TBL] [Abstract][Full Text] [Related]
15. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
16. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
17. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis.
Song J; Liu Z; Zhong W; Huang Y; Ma Z; Dong D; Liang C; Tian J
Sci Rep; 2016 Dec; 6():38282. PubMed ID: 27922113
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.
Tao J; Lv R; Liang C; Fang J; Liu D; Lan X; Huang H; Zhang J
Acad Radiol; 2022 Feb; 29 Suppl 2():S62-S72. PubMed ID: 33402298
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
